Vijay Pande, PhD

Bayesian Health offers an adaptive AI/ML platform that forecasts declining trajectories within a hospital/health system’s patient population. The research-backed platform is designed to empower providers with the ability to identify and intervene with next-best actions in a timely way. This is accomplished by sending accurate and actionable clinical signals for a wide range of critical condition areas within the EMR and existing workflows. As a result, physicians and care team members are able to catch life-threatening complications much earlier, leading to better patient outcomes and reductions in healthcare costs. This pioneering approach is referred to as Intelligent Care Augmentation. Why the name “Bayesian”? Optimal decision making relies on being good at pulling together lots of relevant data, knowing what to trust, integrating these data to create forecasts, and updating forecasts as new data arrive. That’s a Bayesian way of reasoning. Bayesian Health leverages best in class AI/ML techniques to enable this for care teams because decisions around our health deserve the best data and inferences. Learn more at bayesianhealth.com. Select Recognition: - Times Best Invention 2023 https://time.com/collection/best-inventions-2023/6324389/targeted-real-time-early-warning-system/ - Forbes AI 50 2023 https://www.forbes.com/sites/konstantinebuhler/2023/04/11/ai-50-2023-generative-ai-trends/ - WebMD Health Heroes 2024 https://www.webmd.com/healthheroes/suchi-saria - World Economic Forum Tech Pioneer 2023 https://initiatives.weforum.org/technology-pioneers/ - Women Leaders in Healthcare https://www.modernhealthcare.com/awards/2024-women-leaders-suchi-saria - Top 25 Innovators by Modern Healthcare https://www.modernhealthcare.com/awards/2022-top-25-innovators-suchi-saria - Top 50 in Digital Health https://www.top50indigitalhealth.com/past-honorees

Bayesian Health offers an adaptive AI/ML platform that forecasts declining trajectories within a hospital/health system’s patient population. The research-backed platform is designed to empower providers with the ability to identify and intervene with next-best actions in a timely way. This is accomplished by sending accurate and actionable clinical signals for a wide range of critical condition areas within the EMR and existing workflows. As a result, physicians and care team members are able to catch life-threatening complications much earlier, leading to better patient outcomes and reductions in healthcare costs. This pioneering approach is referred to as Intelligent Care Augmentation. Why the name “Bayesian”? Optimal decision making relies on being good at pulling together lots of relevant data, knowing what to trust, integrating these data to create forecasts, and updating forecasts as new data arrive. That’s a Bayesian way of reasoning. Bayesian Health leverages best in class AI/ML techniques to enable this for care teams because decisions around our health deserve the best data and inferences. Learn more at bayesianhealth.com. Select Recognition: - Times Best Invention 2023 https://time.com/collection/best-inventions-2023/6324389/targeted-real-time-early-warning-system/ - Forbes AI 50 2023 https://www.forbes.com/sites/konstantinebuhler/2023/04/11/ai-50-2023-generative-ai-trends/ - WebMD Health Heroes 2024 https://www.webmd.com/healthheroes/suchi-saria - World Economic Forum Tech Pioneer 2023 https://initiatives.weforum.org/technology-pioneers/ - Women Leaders in Healthcare https://www.modernhealthcare.com/awards/2024-women-leaders-suchi-saria - Top 25 Innovators by Modern Healthcare https://www.modernhealthcare.com/awards/2022-top-25-innovators-suchi-saria - Top 50 in Digital Health https://www.top50indigitalhealth.com/past-honorees

Founded in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz (known as "a16z") is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to late-stage technology companies, across the consumer, enterprise, bio/healthcare, crypto, fintech and games spaces. a16z is defined by respect for the entrepreneur and the entrepreneurial company building process; we know what it’s like to be in the founder’s shoes. The firm is led by general partners, many of whom are former founders/operators, CEOs, or CTOs of successful technology companies, and who have domain expertise ranging from biology to crypto to distributed systems to security to marketplaces to financial services. We aim to connect entrepreneurs, investors, executives, engineers, academics, industry experts, and others in the technology ecosystem. We have built a network of experts including technical and executive talent; top media and marketing resources; Fortune 500/Global 2000 companies; as well as other technology decision makers, influencers, and key opinion leaders. a16z uses this network as part of our commitment to help our portfolio companies grow their business, so our operating teams provide entrepreneurs with access to expertise and insights across the entire spectrum of company building. https://a16z.com/portfolio/ https://a16z.com/podcasts/ https://a16z.com/videos/ http://a16z.com/subscribe See Disclosures: https://a16z.com/disclosures/

Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious diseases. Globavir's development strategy harnesses the advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies. Globavir is initially focused on the treatment of dengue virus infection, a potentially lethal disease infecting 390 million patients annually. Through the combination of our proprietary diagnostic technology and advanced therapeutic candidates, Globavir is ideally positioned to rapidly impact the clinical landscape for Dengue patients. Globavir's platform discovery technologies have further identified candidate compounds with efficacy in additional viral indications, including West Nile, Japanese Encephalitis, Ebola, Marburg, and Hunta viruses.

Naughty Dog is the developer of some of the most critically acclaimed and top-selling video games on PlayStation platforms, having created the classic Crash Bandicoot and Jak and Daxter series, as well as modern franchises Uncharted and The Last of Us. The studio is a wholly-owned subsidiary of Sony Interactive Entertainment based out of Santa Monica, CA. Naughty Dog is also home to Sony World Wide Studios’ ICE Team, a central technology group that focuses on creating core graphics technologies for Sony’s worldwide first-party published titles, including low-level game engine components, graphics processing pipelines, supporting tools, and graphics profiling and debugging tools. We are always looking for top tier talent to add to our development team. Visit https://www.naughtydog.com/careers for career opportunities. We offer successful applicants a highly competitive salary and compensation package including a comprehensive benefits package for all full-time hires. Naughty Dog is an equal opportunity employer.